Codrituzumab
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC) .
Product Specifications
CAS Number
1365267-33-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC210877L3V 200 µL
RAB11FIP4 (NM_032932) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 